Conditional approval for Novartis's acquisition of Alcon* Introduction The Ministry of Commerce's Anti-monopoly Bureau approved Novartis's acquisition of Alcon on August 13 2010, subject to conditions.(1) The ministry accepted the filing in respect of the acquisition on April 20 2010 and decided on May 17 2010 that a further review period was needed. The ministry reviewed information on: • the overlap of the two companies' products in the Chinese and global markets; • their respective market shares; • the characteristics,
The Chinese MOFCOM clears with conditions the acquisition of a global supplier in the pharmaceutical sector (Novartis / Alcon)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.